MedStar Authors catalog › Details for: Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?. [Review]
Normal view MARC view ISBD view

Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?. [Review]

by MacKay, Charles R; Torguson, Rebecca; Waksman, Ron.
Citation: Lancet. 386(9994):714-6, 2015 Aug 15..Journal: Lancet (London, England).ISSN: 0140-6736.Full author list: MacKay CR; Torguson R; Waksman R.UI/PMID: 25960111.Subject(s): Disclosure/es [Ethics] | Fibrinolytic Agents/tu [Therapeutic Use] | Humans | *Informed Consent/es [Ethics] | *Myocardial Infarction/th [Therapy] | *Patient Selection/es [Ethics] | *Percutaneous Coronary Intervention/mt [Methods] | Randomized Controlled Trials as Topic/es [Ethics] | Randomized Controlled Trials as Topic/mt [Methods]Institution(s): MedStar Health Research Institute | MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal Article | ReviewOnline resources: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(15)60077-0 (Click here) Abbreviated citation: Lancet. 386(9994):714-6, 2015 Aug 15.Local Holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1983 - 2007.

Powered by Koha